• Publications
  • Influence
Efficacy and safety of topical WBI‐1001 in patients with mild to severe atopic dermatitis: results from a 12‐week, multicentre, randomized, placebo‐controlled double‐blind trial
TLDR
There is a need for the development of novel nonsteroidal topical drugs for the treatment of atopic dermatitis and this work aims to provide a first step in this direction.
Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial
TLDR
There is a need for the development of novel non‐steroidal topical drugs for the treatment of psoriasis and this work highlights the need for such drugs to be developed.